Delivery Order SPE2DB22D3011-SPE2DB25FQ2FJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,076.82 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units). The contract was awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a competitively awarded, non-set-aside transaction with firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packaging) on August 13, 2025, with a ceiling value of $1,715.50 and an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters. The delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) under a firm fixed-price contract with a ceiling value of $1,274.62. The award, issued on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order valued at $4,360.04 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on September 5, 2025, with an ultimate completion date of September 8, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a major distribution hub for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,890.69 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitive award, issued under firm fixed pricing with no set-aside designation, represents a continuation of the company's pharmaceutical supply services to federal medical procurement needs. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,586.06 for 100 tablets of Ambien CR 6.25 mg, with an ultimate completion date of September 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,613.64 for 100 tablets of Ambien CR 6.25 mg on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen...
- The Defense Logistics Agency awarded a $4,118.84 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Ambien CR 6.25 mg on July 22, 2025, with ultimate completion scheduled for July 23, 2025. This contract utilizes firm fixed pricing and carries no set-aside designation, reflecting a competitively awarded transaction. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting...
- The Defense Logistics Agency awarded a delivery order valued at $2,535.99 to AmerisourceBergen Drug Corp for the supply of Ambien CR 6.25 mg tablets (100-count packages) on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100 units, with a contract ceiling value of $3,247.94. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a competitively awarded, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB25FQ2FJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,610.42 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Ambien CR 6.25 mg tablets in quantities of 100. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of August 14, 2025. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. As a critical pharmaceutical distributor for federal military and veteran healthcare systems, AmerisourceBergen Drug Corp fulfills numerous delivery orders through the DLA Medical Supply Chain for a comprehensive portfolio of medications and medical supplies. This particular order for the sedative-hypnotic medication supports the broader pharmaceutical supply mission of the Defense Health Agency and other government healthcare entities. The company's extensive federal contracting history and competitively awarded delivery orders demonstrate its established capability to meet federal procurement requirements across multiple therapeutic domains and price points.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/13/25 |